Coloplast A/S (CLPBY) Stock Chart & Stock Price History $9.75 +0.01 (+0.10%) As of 07/25/2025 03:59 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartDividendEarningsHeadlinesInsider TradesSEC FilingsShort InterestBuy This Stock Coloplast A/S Stock Price Performance The Coloplast A/S (CLPBY) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 24.88%, with a year-to-date return of -10.22%. In the past month, the stock has increased 3.61%, reflecting recent market activity. As of the latest close, Coloplast A/S traded at $9.75 with a market cap of and volume of 57,809 shares. Five years ago, the stock traded at $16.56, representing a 41.12% decrease over that period. At the time, it had a market cap of and a volume of 45,658 shares. Receive CLPBY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Coloplast A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.39%1 Month Performance+3.61%3 Month Performance-11.92%Year-To-Date Performance-10.22%1 Year Performance-24.88%5 Year Performance-41.12% CLPBY Stock Chart for Saturday, July, 26, 2025 CLPBY Chart by TradingView Coloplast A/S Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/25/2025$9.74$9.75+0.10%$9.76$9.6657,809 shs$0.0007/24/2025$9.72$9.74+0.21%$9.82$9.73101,170 shs$0.0007/23/2025$9.59$9.72+1.36%$9.72$9.61196,173 shs$0.0007/22/2025$9.43$9.59+1.70%$9.60$9.44179,354 shs$0.0007/21/2025$9.42$9.43+0.11%$9.47$9.40198,181 shs$0.0007/18/2025$9.39$9.42+0.32%$9.47$9.40195,566 shs$0.0007/17/2025$9.36$9.39+0.32%$9.43$9.31931,497 shs$0.0007/16/2025$9.35$9.36+0.11%$9.41$9.30177,605 shs$0.0007/15/2025$9.38$9.35-0.32%$9.50$9.32177,350 shs$0.0007/14/2025$9.37$9.38+0.11%$9.40$9.35200,034 shs$0.00 Get the Latest News and Ratings for CLPBY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Coloplast A/S and its competitors with MarketBeat's FREE daily newsletter. 07/11/2025$9.53$9.37-1.68%$9.43$9.32259,175 shs$0.0007/10/2025$9.47$9.53+0.63%$9.62$9.48146,724 shs$0.0007/09/2025$9.46$9.47+0.11%$9.49$9.40188,047 shs$0.0007/08/2025$9.27$9.46+2.05%$9.51$9.30334,910 shs$0.0007/07/2025$9.36$9.27-0.96%$9.42$9.25230,128 shs$0.0007/04/2025$9.36$9.36$9.44$9.3179,654 shs$0.0007/03/2025$9.48$9.36-1.27%$9.44$9.3179,654 shs$0.0007/02/2025$9.41$9.48+0.74%$9.50$9.40206,253 shs$0.0007/01/2025$9.48$9.41-0.74%$9.46$9.19161,533 shs$0.0006/30/2025$9.39$9.48+0.96%$9.50$9.40178,401 shs$0.0006/27/2025$9.41$9.39-0.21%$9.46$9.35223,721 shs$0.0006/26/2025$9.43$9.41-0.16%$9.52$9.40144,869 shs$0.0006/25/2025$9.48$9.43-0.53%$9.44$9.34119,009 shs$0.00 Related Companies Advanced Biomedical Technologies Stock Price Chart American Medical Technologies Stock Price Chart Arrayit Stock Price Chart Bionik Laboratories Stock Price Chart CardioGenics Stock Price Chart CytoCore Stock Price Chart DiaSys Stock Price Chart Fresenius Medical Care AG & Co. KGaA Stock Price Chart Hypertension Diagnostics Stock Price Chart Imris Stock Price Chart Receive CLPBY Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Coloplast A/S and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:CLPBY) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredURGENT: Trump Could Buy 1,000,000 Bitcoins TOMORROW?According to one report, senior officials and crypto insiders recently discussed Bitcoin accumulation at the h...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coloplast A/S Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Coloplast A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
